- Home
- STNG vs HRMY Comparison
STNG vs HRMY Comparison
Compare STNG & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNG
- HRMY
- Stock Information
- Founded
- STNG 2009
- HRMY 2017
- Country
- STNG Monaco
- HRMY United States
- Employees
- STNG N/A
- HRMY N/A
- Industry
- STNG Marine Transportation
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- STNG Consumer Discretionary
- HRMY Health Care
- Exchange
- STNG Nasdaq
- HRMY Nasdaq
- Market Cap
- STNG 2.3B
- HRMY 2.0B
- IPO Year
- STNG 2010
- HRMY 2020
- Fundamental
- Price
- STNG $44.32
- HRMY $32.49
- Analyst Decision
- STNG Buy
- HRMY Strong Buy
- Analyst Count
- STNG 4
- HRMY 9
- Target Price
- STNG $60.50
- HRMY $54.22
- AVG Volume (30 Days)
- STNG 763.3K
- HRMY 649.0K
- Earning Date
- STNG 07-29-2025
- HRMY 08-05-2025
- Dividend Yield
- STNG 3.61%
- HRMY N/A
- EPS Growth
- STNG N/A
- HRMY 13.13
- EPS
- STNG 10.31
- HRMY 2.62
- Revenue
- STNG $1,066,599,000.00
- HRMY $744,852,000.00
- Revenue This Year
- STNG N/A
- HRMY $20.10
- Revenue Next Year
- STNG $1.73
- HRMY $18.01
- P/E Ratio
- STNG $4.30
- HRMY $12.39
- Revenue Growth
- STNG N/A
- HRMY 20.62
- 52 Week Low
- STNG $30.63
- HRMY $26.47
- 52 Week High
- STNG $84.67
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- STNG 65.60
- HRMY 38.32
- Support Level
- STNG $41.16
- HRMY $32.39
- Resistance Level
- STNG $40.51
- HRMY $33.42
- Average True Range (ATR)
- STNG 1.56
- HRMY 1.03
- MACD
- STNG 0.38
- HRMY -0.46
- Stochastic Oscillator
- STNG 90.79
- HRMY 3.24
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owns, lease finances or bareboat charters in hundred ten product tankers namely thirty nine LR2 tankers, fifty seven MR tankers and forteeen Handymax tankers. The company's fleet of tankers is the largest, most eco-friendly and newest fleet on the water hauling clean petroleum products. They provide seaborne transportation of crude oil and refined petroleum products worldwide. The company generates majority of its revenue from MR vessel.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.